And in a report last year, a panel appointed by the National Research Council recommended that the National Science Foundation, the major government financing agency for physical science research, offer prizes of $200,000 to $2 million "in diverse areas" as a first step in a major program "to encourage more complex innovations" addressing economic, social and other challenges.
Simple innovations can be often done by employees involved, whereas attaining more complex innovations usually entails joint effort, i.e., teamwork based upon a range of precise knowledge, competence, and work roles (Janssen 2000).
To summarize, firms today must navigate a more complex innovation environment, build and maintain a richer set of alliances, and counter a wider range of competitors from both expected and unexpected quarters than ever before.
Pittaway et al. (2004) also found that more complex innovation processes benefit from engagement with a diverse range of partners which allows for the integration of different knowledge bases, behaviours and habits of thought.
Making matters more complex, new innovations must be deployed by companies and used by the public.
"In the years running up to 2007, too much of the developed world's intellectual talent was devoted to ever more complex financial innovations, whose maximum possible benefit was at best marginal, and which in their complexity and opacity created large financial stability risks," he said.
The more complex the innovation, the lower rate of diffusion could be expected.
Deleuze's prose can be highly allusive, as well as peppered with neologisms; to make matters even more complex, these terminological innovations shift from one work to the other.
The analyzed method also identifies the circumstances under which different theories apply and shows how the combination of elements from these theories can lead to more complex theories of innovation and change processes.
The IP system is under increasing strain because of the more complex character of technological innovation today, the more complex patterns of research and development, and the globalized nature of business.
The matter is further complicated by the fact that research is becoming more expensive, research structures are growing more complex and fractured, and innovation levels, at least in the pharmaceutical setting, are not increasing [ 1].
